All In Biotech

Drug Trial Radar · NCT00930644

Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

A Long-Term, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition Dependent Short Bowel Syndrome

Last checked: Nov 19, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

88

Actual

Start

Sep 21, 2009

Primary completion

Jan 24, 2013

Study completion Jan 24, 2013

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
Collaborators
Nycomed Germany GmbH
First posted
Jun 30, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a 2-year open label extension study to collect long term efficacy and safety data from patients who have completed the 24-weeks of study drug dosing in CL0600-020.

Conditions

  • Short Bowel Syndrome

Interventions

  • teduglutideDrug

    0.05 mg/kg/day subcutaneously taken once per day for 24 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change in PN/IV Volume by VisitTime frame: 24 months
  2. Absolute Change in PN/IV Volume by VisitTime frame: 24 months

Locations

23 sites in 9 countries. Site status is shown where the registry gives one.

  • Scripps Clinic & Research Foundation

    La Jolla, California

  • Mount Sinai Medical Center

    New York, New York

  • Cleveland Clinic Foundation

    Cleveland, Ohio

  • University of Pennslyvania

    Philadelphia, Pennsylvania

  • University Of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Royal Alexandra Hospital

    Edmonton, Alberta, Canada

  • St. Michael's Hospital

    Toronto, Ontario, Canada

  • University Health Network - Toronto General Hospital

    Toronto, Ontario, Canada

  • Rigshospitalet

    Copenhagen, Denmark

  • Hôpital Beaujon

    Clichy, France

  • Hopital de l'Archet 2

    Nice, France

  • Universitaetsklinikum Tuebingen Medizinische Klinik I

    Tübingen, Baden-Wurttemberg, Germany

  • Med. Klinik m.S. Hepatologie und Gastroenterologie

    Berlin, State of Berlin, Germany

  • Azienda Universitaria Policlinico Federico II

    Naples, Italy

  • Wojewodzki Szpital Specjalistyczny im. M. Pirogowa, Pracownia Leczenia Zywieniowego

    Lodz, Poland

  • Samodzielny Publiczny Szpital Kliniczny nr 4, Klinika Chirurgii Ogolnej i Transplantacyjnej

    Lublin, Poland

  • Pracownia Żywienia Klinicznego

    Olsztyn, Poland

  • Samodzielny Publiczny Szpital Kliniczny-Im.prof W.Orłowskiego CMKP

    Warsaw, Poland

  • Hospital Universitario de Bellvitge

    Barcelona, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Spain

  • St. Marks Hospital

    Harrow, United Kingdom

  • University College London Hospital

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.